Recruiting
Phase 3

A Study of Baricitinib (LY3009104) in Children With COVID-19

Sponsor:

Eli Lilly and Company

Code:

NCT05074420

Conditions

Covid19

Corona Virus Infection

Eligibility Criteria

Sex: All

Age: 2 - 18

Healthy Volunteers: Not accepted

Interventions

Baricitinib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information